These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30567819)

  • 1. Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan.
    Hsieh CI; Kuo RN; Liang CC; Tsai HY; Chung KP
    BMJ Open; 2018 Dec; 8(12):e021341. PubMed ID: 30567819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists.
    van Erning FN; Janssen-Heijnen ML; Creemers GJ; Pruijt HF; Maas HA; Lemmens VE
    J Geriatr Oncol; 2015 May; 6(3):219-24. PubMed ID: 25703856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
    Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
    J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
    Liang YH; Shao YY; Chen HM; Cheng AL; Lai MS; Yeh KH
    Anticancer Res; 2017 Dec; 37(12):7095-7104. PubMed ID: 29187501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of colon cancer initially presenting as colon perforation and obstruction.
    Chen TM; Huang YT; Wang GC
    World J Surg Oncol; 2017 Aug; 15(1):164. PubMed ID: 28841901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials.
    Batra A; Kong S; Cheung WY
    Clin Colorectal Cancer; 2020 Dec; 19(4):e226-e234. PubMed ID: 32636076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.
    Eheman CR; O'Neil ME; Styles TS; Thompson TD; Morris CR; Babcock FA; Chen VW
    J Registry Manag; 2016; 43(4):179-186. PubMed ID: 29308117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis.
    Chen PH; Wu YY; Lee CH; Chung CH; Chen YG; Huang TC; Yeh RH; Chang PY; Dai MS; Lai SW; Ho CL; Chen JH; Chen YC; Hu JM; Yang SS; Chien WC
    Medicine (Baltimore); 2021 May; 100(18):e25756. PubMed ID: 33950962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
    Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
    Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
    Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
    Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy.
    Croese A; Gartrell R; Hiscock R; Lee M; Gibbs P; Faragher I; Yeung J
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1346. PubMed ID: 33554476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments for Stage IV Colon Cancer and Overall Survival.
    Xu Z; Becerra AZ; Fleming FJ; Aquina CT; Dolan JG; Monson JR; Temple LK; Jusko TA
    J Surg Res; 2019 Oct; 242():47-54. PubMed ID: 31071604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.
    Hussain T; Chang HY; Veenstra CM; Pollack CE
    J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.